Abstract
The antibacterial activity of antimicrobial peptides produced by strain LFB 112 was determined using the cup-plate method and a standard curve of penicillin. An effective method to evaluate the antimicrobial activity of antibacterial peptides was established. Three active fractions, Fraction A (5.0–5.5 kDa), Fraction B (3.0–3.5 kDa) and Fraction C (400–800 Da), were separated by anion-exchange, reversed phase liquid chromatography (RPLC) and gel filtration chromatography. Fraction A contained an antimicrobial peptide; its partial sequence (LVQSPNGNFAASFVLDGTK), determined by liquid chromatography-mass spectrometry (LC-MS), was homologous with antimicrobial peptide LCI. In addition, there were three major ingredients in fraction B (3,371.811, 3,442.379 and 3,486.596 Da, respectively), and several small peptides (400–800 Da) in fraction C. After purification, the potencies of fractions A, B and C were 188.6, 11,217.26 and 10,290.63 U/mg, respectively. Furthermore, antimicrobial peptides in fraction B, apparently different from known antimicrobial peptides produced by Bacillus subtilis (based on molecular weight), and small (molecular weight 400–800 Da) antimicrobial peptides produced by B. subtilis LFB112 were also identified. Antimicrobial peptides produced by strain LFB112 with high potency against several undesirable bacteria were identified. These compounds have potential as alternatives to known antibiotics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
